University of Copenhagen researchers have discovered a surprising tactic of pathogenic bacteria when being attacked by antibiotics: hibernation. Almost all
Read more
Home » Pharmacology »
In zebrafish, a way to find new cancer therapies, targeting tumor modulators: Rapid drug testing with zebrafish may soon lead to clinical trial of retinoic acid for adenoid cystic carcinoma:
The lab of Leonard Zon, MD, at Boston Children’s Hospital has long been interested in making blood stem cells in
Read more
New test procedure accelerates the diagnosis of multi-resistant hospital pathogens
A team of researchers at the University of Cologne’s Faculty of Medicine and the German Center for Infection Research (DZIF)
Read more
E. coli’s adaptation to extreme temperatures helps explain resistance to certain drugs
Long before bacteria had to contend with antibiotic drugs, they had to survive extreme temperatures as Earth warmed and cooled
Read more
New nanoparticles wait to release drugs, target infection
Current WSU research shows stimuli-responsive nanoparticles can specifically target infections to simultaneously prevent the spread of bacteria and reduce the
Read more
Racial disparities in prescribing opioids for chronic pain
Yale researchers have identified racial disparities in the treatment of patients who are prescribed opioids for chronic pain. Black patients
Read more
Drug repurposing study sheds light on heart disease risk: Research team develops computer program for investigating unknown drug side effects and novel uses
A team led by researchers at Brigham and Women’s Hospital has developed a computational technique to reveal the unknown side
Read more
The medicine of the future against infection and inflammation?
Researchers at Lund University in Sweden, have in collaboration with colleagues in Copenhagen and Singapore, mapped how the body’s own
Read more
Latent TB treatment: Shorter is better: Game-changing study on treatment of latent Tuberculosis shows a novel, short therapy is safer and more effective in children and adults than standard therapy
Treatment of latent tuberculosis is set to transform after a pair of studies from the Research-Institute of the McGill University
Read more
Pay less, take more: Success in getting patients to take their medicine: Basing patients’ medication costs on the health benefits they’ll get from a drug, rather than its price, means they’re more likely to take it
Taking a medicine every day in the hopes that it will prevent some long-range potential health catastrophe — like a
Read more